Skip to main content
logo
LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · Real-Time Price · USD
1.430
+0.030 (2.14%)
At close: Jul 18, 2025, 4:00 PM
1.420
-0.010 (-0.70%)
After-hours: Jul 18, 2025, 4:04 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20
Novel Bispecific Antibodies
7.32M
Log In
Log In
Log In
Novel Bispecific Antibodies Growth
-64.09%
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20
Netherlands
7.32M
Log In
Log In
Log In
Netherlands Growth
-64.09%
Log In
Log In
Log In